Pain
News
FDA to expand opioid labeling with instructions on proper tapering
The label changes are intended to be used when both the clinician and patient have agreed to reduce the opioid dosage.
News
Romosozumab gets FDA approval for treating osteoporosis
The pair of injections mainly works by encouraging new bone formation.
Conference Coverage
NIH’s HEAL initiative seeks coordinated effort to tackle pain, addiction
MILWAUKEE – The two aims of research under the initiative are to improve treatments for misuse and addiction, and to enhance pain management.
From the Journals
Rituximab does not improve fatigue symptoms of ME/CFS
Results from the phase 3 RituxME trial found no difference in fatigue score symptoms after 24 months.
Feature
Report calls for focus on ‘subpopulations’ to fight opioid epidemic
“Methadone, buprenorphine, and extended-release naltrexone ... save lives” but most people with OUD get no treatment, new report says.
From the Journals
Surge of gabapentinoids for pain lacks supporting evidence
Review of 54 papers for gabapentin and 30 for pregabalin finds little evidence for effective pain control in off-label uses.
Video
Through the eyes of migraine: Ocular considerations
STOWE, VT. – Dr. Kathleen Digre discusses the eye’s role in migraine.
Video
CGRP drugs: How is it going?
STOWE, VT. – Dr. Peter McAllister summarizes postmarketing experiences with CGRP monoclonal antibodies for migraine prevention.
Conference Coverage
Opioid overdose risk greater among HIV patients
From the Journals
Possible mortality risk seen with tramadol in osteoarthritis
Older patients taking tramadol for osteoarthritis had significantly higher mortality risk than did patients taking NSAIDs.
Conference Coverage
Migraine associated with more severe disability in patients with MS
DALLAS – “Traditional migraine risk factors such as obesity, anxiety, and depression were also overrepresented in our cohort” of patients with MS...